Nicotinamide Mononucleotide, an Intermediate of NAD+ Synthesis, Protects the Heart from Ischemia and Reperfusion
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme for nicotinamide adenine dinucleotide (NAD+) synthesis, and Sirt1, an NAD+-dependent histone deacetylase, protect the heart against ischemia/reperfusion (I/R). It remains unknown whether Nampt mediates the protective effect of ischemic preconditioning (IPC), whether nicotinamide mononucleotide (NMN, 500 mg/kg), a product of Nampt in the NAD+ salvage pathway, mimics the effect of IPC, or whether caloric restriction (CR) upregulates Nampt and protects the heart through a Sirt1-dependent mechanism. IPC upregulated Nampt protein, and the protective effect of IPC against ischemia (30 minutes) and reperfusion (24 hours) was attenuated at both early and late phases in Nampt +/- mice, suggesting that Nampt plays an essential role in mediating the protective effect of IPC. In order to mimic the effect of Nampt, NMN was administered by intraperitoneal injection. NMN significantly increased the level of NAD+ in the heart at baseline and prevented a decrease in NAD+ during ischemia. NMN protected the heart from I/R injury when it was applied once 30 minutes before ischemia or 4 times just before and during reperfusion, suggesting that exogenous NMN protects the heart from I/R injury in both ischemic and reperfusion phases. The protective effect of NMN was accompanied by decreases in acetylation of FoxO1, but it was not obvious in Sirt1 KO mice, suggesting that the effect of NMN is mediated through activation of Sirt1. Compared to control diet (90% calories), CR (60% calories for 6 weeks) in mice led to a significant reduction in I/R injury, accompanied by upregulation of Nampt. The protective effect of CR against I/R injury was not significant in cardiac-specific Sirt1 KO mice, suggesting that the protective effect of CR is in part mediated through the Nampt-Sirt1 pathway. In conclusion, exogenous application of NMN and CR protects the heart by both mimicking IPC and activating Sirt1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, they have demonstrated beneficial pharmacological activities in acute renal failure [28], anti-inflammatory [29–31], cardio and vasoprotective actions [32–35], telomere lengthening [36, 37•], extend lifespan and promote health in various organisms, from yeasts to mammals [10, 14, 15, 38].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis, oncosis, and necrosis. An overview of cell death.
Majno, G., & Joris, I. (1995) · PubMed Central · Cited by 4,150
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510 · cited 1×
“Since the deacetylase activity of Sirt1 critically depends upon the intracellular level of nicotinamide adenine dinucleotide (NAD) [10], NAD may be an alternative target for promoting IPC through Sirt1.”
BackgroundMatsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., Asano, T., Levine, B., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000261924.76669.36 · Cited by 1,505 · cited 12×
“ATP Assays Primary cultured myocytes were plated on 12 well dishes with 1 ml/well myocyte medium (BrdU (+)).”
BackgroundSelf-citationSirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart
Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S. F., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000267723.65696.4a · Cited by 1,147 · cited 2×
“sufficient to protect the heart from oxidative stress [9] and I/R”
BackgroundSelf-citationCircadian Clock Feedback Cycle Through NAMPT-Mediated NAD + Biosynthesis
Ramsey, K. M., Yoshino, J., Brace, C. S., Abrassart, D., Kobayashi, Y., Marcheva, B., Hong, H.-K., Chong, J. L., Buhr, E. D., Lee, C., et al. (2009) · Science · doi:10.1126/science.1171641 · Cited by 1,126 · cited 1×
“Expression of Nampt is also regulated by CLOCK:BMAL1, the key genes in the circadian mechanism [29].”
BackgroundNampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911 · cited 1×
“Interestingly, NMN, the product of the ratelimiting enzyme in the NAD salvage pathway, has been used previously in order to achieve the same effect as overexpression of Nampt, where the administration of NMN caused a partial recovery of insulin secretion from pancreatic b-cells [14] in Nampt +/2 mice.”
MethodFulco, M., Cen, Y., Zhao, P., Hoffman, E. P., McBurney, M. W., Sauve, A. A., & Sartorelli, V. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.02.004 · Cited by 820 · cited 1×
“Nampt is regulated by HIF1a [25], FoxO [26], and LXR [27] transcription factors, as well as through an AMPK-dependent mechanism [28].”
BackgroundHariharan, N., Maejima, Y., Nakae, J., Paik, J., DePinho, R. A., & Sadoshima, J. (2010) · Circulation Research · doi:10.1161/circresaha.110.227371 · Cited by 692 · cited 2×
“This is consistent with our previous observations that both Nampt and Sirt1 promote autophagy in cardiomyocytes [13,16].”
MethodResultSelf-citationSilent Information Regulator 1 Protects the Heart From Ischemia/Reperfusion
Hsu, C.-P., Zhai, P., Yamamoto, T., Maejima, Y., Matsushima, S., Hariharan, N., Shao, D., Takagi, H., Oka, S., & Sadoshima, J. (2010) · Circulation · doi:10.1161/circulationaha.110.958033 · Cited by 560 · cited 5×
“injury through deacetylation of FoxO transcription factors [8].”
BackgroundResultSelf-citation
Cited by
Items 101–200 of 315
Mitochondrial sirtuins in the heart
Bugger, H., Witt, C. N., & Bode, C. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9570-7 · Cited by 48
Hu, M.-Z., Zhou, B., Mao, H.-Y., Sheng, Q., Du, B., Chen, J., Pang, Q., & Ji, Y. H. (2016) · International Heart Journal · doi:10.1536/ihj.15-506 · Cited by 53
Regulatory Effects of NAD + Metabolic Pathways on Sirtuin Activity
Zhang, N., & Sauve, A. A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.012 · Cited by 50
Xie, L., Wang, Z., Li, C., Yang, K., & Liang, Y. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2016.10.038 · Cited by 46
“NAD is a substrate for PARP-1, a protein involved in DNA repair and programmed cell death [32,33].”
Mitochondrial regulation of cardiac aging
Wang, Y., Li, Y., He, C., Gou, B., & Song, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.12.008 · Cited by 46
Wang, Y.-J., Paneni, F., Stein, S., & Matter, C. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.755060 · Cited by 52
Huang, P., Wang, X., Wang, S., Wu, Z., Zhou, Z., Shao, G., Ren, C., Kuang, M., Zhou, Y., Jiang, A., et al. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.08.011 · Cited by 43
Walker, M. A., Chen, H., Yadav, A. S., Ritterhoff, J., Villet, O. M., McMillen, T. S., Wang, Y., Purcell, H. J., Djukovic, D., Raftery, D., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.066039 · Cited by 43
Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism
Klimova, N., & Kristián, T. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02729-0 · Cited by 44
Metabolic Reprogramming: Strategy for Ischemic Stroke Treatment by Ischemic Preconditioning
Liang, J., Han, R., & Zhou, B. (2021) · Biology · doi:10.3390/biology10050424 · Cited by 49
“Studies have shown that IPC upregulates NAMPT protein, and the protective effect of IPC against ischemia (30 min) and reperfusion (24 h) was attenuated in NAMPT knockdown mice, suggesting that NAMPT is essential in mediating the protective effect of IPC [80].”
BackgroundBalancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
Cercillieux, A., Ciarlo, E., & Cantó, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04499-5 · Cited by 42
“Similarly, reduced cardiac NAD+ levels are found in situations of dilated cardiomyopathy [94], ischemia [95] or pathological hypertrophy [96].”
BackgroundYamamoto, T., Tamaki, K., Shirakawa, K., Ito, K., Yan, X., Katsumata, Y., Anzai, A., Matsuhashi, T., Endo, J., Inaba, T., et al. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00676.2015 · Cited by 41
Self-citationYano, M., Akazawa, H., Oka, T., Yabumoto, C., Kudo-Sakamoto, Y., Kamo, T., Shimizu, Y., Yagi, H., Naito, A. T., Lee, J.-K., et al. (2015) · Scientific Reports · doi:10.1038/srep15857 · Cited by 39
The emergence of the nicotinamide riboside kinases in the regulation of NAD+ metabolism
Fletcher, R. S., & Lavery, G. G. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0085 · Cited by 38
Improving lysosomal ferroptosis with NMN administration protects against heart failure
Yagi, M., Do, Y., Hirai, H., Miki, K., Toshima, T., Fukahori, Y., Setoyama, D., Abe, C., Nabeshima, Y., Kang, D., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202302116 · Cited by 41
“NAD + levels in the hearts of mice protects against ischemia – reperfusion injury (Yamamoto et al, 2014; Yoshino et al, 2018).”
BackgroundCaloric restriction mimetics for the treatment of cardiovascular diseases
Sciarretta, S., Forte, M., Castoldi, F., Frati, G., Versaci, F., Sadoshima, J., Kroemer, G., & Maiuri, M. C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa297 · Cited by 41
Self-citationXie, W., Zhu, T., Zhou, P., Xu, H., Meng, X., Ding, T., Nan, F., Sun, G., & Sun, X. (2020) · Journal of Ginseng Research · doi:10.1016/j.jgr.2020.11.004 · Cited by 40
Zhang, J., Yu, J. M., Chen, Y., Liu, L., Xu, M., Sun, L., Luo, H., Wang, Y., & Meng, G. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9396089 · Cited by 41
Li, M., Jiao, L., Shao, Y., Li, H., Sun, L., Qi, Y., Gong, M., Liu, D., Wang, Y., Xuan, L., et al. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.06.004 · Cited by 38
“Importantly, NMN protects the MIRI by increasing the level of NADþ in the heart.(29) However, whether NMN is related to DNA methylation in MIRI remains unknown.”
BackgroundInfluentialCellular senescence as a therapeutic target to improve renal transplantation outcome
van Willigenburg, H., de Keizer, P. L. J., & de Bruin, R. W. F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.015 · Cited by 38
Control of NAD+ homeostasis by autophagic flux modulates mitochondrial and cardiac function
Zhang, Q., Li, Z., Li, Q., Trammell, S. A. J., Schmidt, M. S., Pires, K. M. P., Cai, J., Zhang, Y., Kenny, H., Boudina, S., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-023-00009-w · Cited by 40
“NAD + de fi ciency, therefore, has been considered one mechanism for heart failure (Yamamoto et al, 2014; Yano et al, 2015).”
Collier, J. B., & Schnellmann, R. G. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03391-z · Cited by 38
Post-translational Acetylation Control of Cardiac Energy Metabolism
Ketema, E. B., & Lopaschuk, G. D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.723996 · Cited by 42
“found no additional susceptibility to I/R-specific injury in SIRT3 KO mice that underwent permanent ligation of the left anterior descending coronary artery (LAD) (125).”
BackgroundInfluentialNicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions
Hosseini, L., Vafaee, M. S., Mahmoudi, J., & Badalzadeh, R. (2019) · Biogerontology · doi:10.1007/s10522-019-09805-6 · Cited by 40
Regulation of cardiac O-GlcNAcylation: More than just nutrient availability
Collins, H. E., & Chatham, J. C. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165712 · Cited by 36
“Interestingly, NAD+ and its precursors have been shown to be cardioprotective in the setting of I/R injury[112, 113], which would seem counterintuitive given that lower O-GlcNAc levels have been associated with greater injury in similar settings[24].”
BackgroundLi, L., Li, H., Tien, C., Jain, M. K., & Zhang, L. (2020) · Circulation · doi:10.1161/circulationaha.119.041664 · Cited by 37
He, Z., Yang, X., Tian, X., Li, L., & Liu, M. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00350 · Cited by 38
Sirtuins, aging, and cardiovascular risks
Favero, G., Franceschetti, L., Rodella, L. F., & Rezzani, R. (2015) · AGE · doi:10.1007/s11357-015-9804-y · Cited by 37
“Yamamoto et al. (2014) observed that since caloric restriction, which protects the heart from ischemia/ reperfusion injury, failed to induce cardioprotection in SIRT1 knockout mice, the cardioprotective effect of caloric restriction is in part mediated through activation of the Nampt-SIRT1 pathway,…”
Xu, W., Li, L., & Zhang, L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00901 · Cited by 35
“First, the SIRT1/FOXO1 pathway is upregulated by NAD+ restoration in response to I/R injury (Yamamoto et al., 2014; Guan et al., 2016; Zhang et al., 2016).”
BackgroundRole and Potential Mechanisms of Nicotinamide Mononucleotide in Aging
Rahman, S. U., Qadeer, A., & Wu, Z. (2024) · Aging and disease · doi:10.14336/ad.2023.0519-1 · Cited by 34
“In addition, NMN has been found to protect the heart against damage caused by ischemia/reperfusion injury by inhibiting the reduction of NAD + that typically occurs during ischemia [22].”
BackgroundThe Regulatory Role of NAD in Human and Animal Cells
Kulikova, V., Gromyko, D. V., & Nikiforov, A. A. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918070040 · Cited by 41
Ageing and longevity genes in cardiovascular diseases
Liberale, L., Kraler, S. C., Camici, G. G., & Lüscher, T. F. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13426 · Cited by 35
NAD + Precursors in Human Health and Disease: Current Status and Future Prospects
Yaku, K., & Nakagawa, T. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0354 · Cited by 33
“…alcoholic liver injury, liver fibrosis, neuroinflammation, heart injury, and kidney injury (Canto´ et al., 2012; Caton et al., 2011; Cerutti et al., 2014; Gariani et al., 2016; Guan et al., 2017; Jiang et al., 2019; Joshi et al., 2020; Wang et al., 2018; Yamamoto et al., 2014; Yoshino et al., 2011).”
Bao, Y. W., Hu, C., Wang, B., Liu, X., Wu, Q., Xu, D., Shi, Z., & Sun, C. (2025) · Biology · doi:10.3390/biology14091140 · Cited by 42
“Nicoti-namide mononucleotide (NMN) increases cardiac NAD + , restoring the NAD + /NADH ratio and reducing RET-associated ROS [105].”
NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair
Wang, P., Li, W.-L., Liu, J.-M., & Miao, C.-Y. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000332 · Cited by 32
Kong, Y., Li, G., Zhang, W., Hua, X., Zhou, C., Xu, T., Li, Z., Wang, P., & Miao, C. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0207-3 · Cited by 34
“Nampt or its substrates displayed protective actions in various cardio-cerebral vascular diseases, such as cerebral ischemia/hemorrhage [27–30], myocardial ischemia and reperfusion [5, 31], post-ischemic vascular repair [32], diabetic vascular malfunction [33], and vascular aging [34].”
BackgroundNon-canonical roles of NAMPT and PARP in inflammation
Martínez-Morcillo, F. J., Cantón-Sandoval, J., Martínez‐Menchón, T., Corbalán-Vélez, R., Mesa-del-Castillo, P., Pérez‐Oliva, A. B., García‐Moreno, D., & Mulero, V. (2020) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2020.103881 · Cited by 35
Poljšak, B., Kovač, V., & Milisav, I. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8819627 · Cited by 36
Ramanathan, C., Lackie, T., Williams, D. H., Simone, P. S., Zhang, Y., & Bloomer, R. J. (2022) · Nutrients · doi:10.3390/nu14020300 · Cited by 35
“Studies from rodents have demonstrated that physiological NMN administration effectively enhances NAD+ biosynthesis in multiple peripheral tissues, including the pancreas [11], liver [11,15,16], adipose tissue [17], heart [18,19], skeletal muscle [10], kidney [20], eyes [21], and blood vessels [22].”
BackgroundQiu, Z., Ming, H., Zhang, Y., Yu, Y., Lei, S., & Xia, Z. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07159-1 · Cited by 35
Wu, W., Yuan, S., Tang, Y., Meng, X., Peng, M., Hu, Z., & Liu, W. (2023) · Nutrients · doi:10.3390/nu15132851 · Cited by 30
Role of Sirtuins in Maintenance of Genomic Stability: Relevance to Cancer and Healthy Aging
Wu, X., Neng, C., Fenech, M. F., & Wang, X. (2016) · DNA and Cell Biology · doi:10.1089/dna.2016.3280 · Cited by 34
“In addition, other studies have reported that pharmacologic inhibition or partial genetic ablation of SIRT1 blocks IPC in adult mouse hearts (Yamamoto et al. , 2014), suggesting that IPC has an endogenous protective role for SIRT1.”
Uddin, G. M., Youngson, N. A., Chowdhury, S. S., Hagan, C., Sinclair, D. A., & Morris, M. J. (2020) · Cells · doi:10.3390/cells9040791 · Cited by 32
“Various rodent studies that used single or multiple NMN doses (range 300–500 mg/kg) have shown beneficial effects in cardiac injury [33], heart failure [34], improved brain function and memory [35], enhanced mitochondrial oxidative metabolism [36] and hepatic mitochondrial respiration [15].”
BackgroundSignaling pathways leading to ischemic mitochondrial neuroprotection
Thompson, J. W., Narayanan, S., Koronowski, K. B., Morris-Blanco, K. C., Dave, K. R., & Pérez‐Pinzón, M. A. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9574-8 · Cited by 35
“Studies from the heart and brain have shown that IPC enhances levels of nicotinamide phoshphoribosyltransferase (Nampt) (Morris-Blanco et al. 2014; Yamamoto et al. 2014), the rate-limiting enzyme in the major biosynthetic pathways for the production of NAD (Revollo et al. 2007).”
Xing, S., Hu, Y., Huang, X., Shen, D., & Chen, C. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10782 · Cited by 40
“…affect cell metabolism and nad + synthesis, interfering with nad + dependent-related protein expression (38,42). recently, studies have demonstrated that naMPT is associated with central nervous system diseases, in that it can protect neurons and delay the occurrence of axonal degeneration (43,44).”
Implications of NAD + boosters in translational medicine
Kang, B. E., Choi, J., Stein, S., & Ryu, D. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13334 · Cited by 35
Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration
Liu, S., Deshmukh, V., Meng, F., Wang, Y., Morikawa, Y., Steimle, J. D., Li, G., Wang, J., & Martin, J. F. (2024) · Circulation · doi:10.1161/circulationaha.123.067646 · Cited by 37
Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases
Rotllán, N., Camacho, M., Tondo, M., Diarte‐Añazco, E. M. G., Canyelles, M., Méndez‐Lara, K. A., Benítez, S., Alonso, N., Mauricio, D., Escolá‐Gil, J. C., et al. (2021) · Antioxidants · doi:10.3390/antiox10121939 · Cited by 34
Design of an in vitro multienzyme cascade system for the biosynthesis of nicotinamide mononucleotide
Zhou, C.-L., Feng, J., Wang, J., Hao, N., Wang, X., & Chen, K. (2022) · Catalysis Science & Technology · doi:10.1039/d1cy01798e · Cited by 31
Therapeutic potential of nicotinamide adenine dinucleotide (NAD)
Arenas‐Jal, M., Suñé-Negre, J. M., & García‐Montoya, E. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173158 · Cited by 36
Li, L., Zhi, D., Cheng, R., Li, J., Luo, C., & Li, H. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135736 · Cited by 30
Metabolic needs of the kidney graft undergoing normothermic machine perfusion
Arykbaeva, A. S., de Vries, D. K., Doppenberg, J. B., Engelse, M. A., Hankemeier, T., Harms, A. C., Wijermars, L. G. M., Schaapherder, A. F., Bakker, J. A., Ploeg, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.04.001 · Cited by 32
NAD+-boosting molecules suppress mast cell degranulation and anaphylactic responses in mice
Kim, H.-W., Ryoo, G.-H., Jang, H., Rah, S., Lee, D. H., Kim, D., Bae, E. J., & Park, B. (2022) · Theranostics · doi:10.7150/thno.69684 · Cited by 27
“Taking account of these findings, as well as the fact that exogenous NMN functions in a transient manner [25], we decided to treat mice three times with NMN and NR at a maximal dose of 100 and 150 mg/kg respectively via intraperitoneal injection.”
BackgroundYang, K., Gao, B., Wei, W., Li, Z., Pan, L., Zhang, J., Zhao, Q., Chen, W., & Xu, Z.-Y. (2015) · Europe PMC (PubMed Central) · Cited by 29
NAD metabolism in aging and cancer
Kincaid, J. W. R., & Berger, N. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220929287 · Cited by 31
“In vivo, these findings were averted by pretreatment with IP injections of NMN,(104) resulting in increased SIRT1 activity and decreased infarct size.(253) Moreover, intravenous NAD infusion has been shown to reduce infarct size as well as decrease troponin 1 levels and apoptosis in a murine model of IR.”
BackgroundTHE CARDIOVASCULAR IMPACT OF VISFATIN - AN INFLAMMATION PREDICTOR BIOMARKER IN METABOLIC SYNDROME
Hognogi, L. D. M., & Vida-Simiti, L. A. (2015) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-591 · Cited by 29
“Also, Visfatin, which was previously linked to the pre-B cell maturation pathway (also named pre-B cell colony enhacing factor), is abundantly expressed in the visceral adipose tissue and its expression is up-regulated by other cytokines [7].”
BackgroundJafari-Azad, A., Hosseini, L., Rajabi, M., Høilund‐Carlsen, P. F., Vafaee, M. S., Feyzizadeh, S., & Badalzadeh, R. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06351-8 · Cited by 27
Marinescu, G. C., Popescu, R. G., & Dinischiotu, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-22806-8 · Cited by 28
NAD+ and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities
Abdellatif, M., Bugger, H., Kroemer, G., & Sedej, S. (2022) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2022.11.2.111 · Cited by 35
Iron deficiency in myocardial ischaemia: molecular mechanisms and therapeutic perspectives
Corradi, F., Masini, G., Bucciarelli, T., & Caterina, R. D. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad146 · Cited by 28
Sirtuin 1 in rat orthotopic liver transplantation: An IGL-1 preservation solution approach
Pantazi, E. D., Zaoualí, M. A., Béjaoui, M., Folch‐Puy, E., Abdennebi, H. B., Varela, A. T. I. F., Rolo, A. P., Palmeira, C. M., & Roselló‐Catafau, J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i6.1765 · Cited by 26
Benjamin, C., & Crews, R. (2024) · Metabolites · doi:10.3390/metabo14060341 · Cited by 26
“…NMN is studied extensively and has displayed several benefits such as improved mitochondrial metabolism, insulin secretion, The liver is the primary site for NAD+ synthesis from tryptophan, as most cells lack the enzymes required for the de novo pathway [28]. and ischemia, to name a few [35,36].”
BackgroundNicotinamide Mononucleotide: Research Process in Cardiovascular Diseases
Deng, H., Ding, D., Ma, Y., Zhang, H., Wang, N., Zhang, C., & Yang, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179526 · Cited by 25
NAMPT inhibitor and metabolite protect mouse brain from cryoinjury through distinct mechanisms
Zhang, X.-Q., Lu, J., Jiang, W., Lu, Y., Wu, M., Wei, E., Zhang, W.-P., & Tang, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.007 · Cited by 27
Jenwitheesuk, A., Park, S., Wongchitrat, P., Tocharus, J., Mukda, S., Shimokawa, I., & Govitrapong, P. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2369-7 · Cited by 26
Chen, L., Chen, M., Yang, X., Hu, Y., Qiu, C., Fu, Y., Lan, X., Luo, G., Liu, Q., & Liu, M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1617305 · Cited by 28
The Science Behind NMN-A Stable, Reliable NAD+Activator and Anti-Aging Molecule.
Shade, C. W. (2020) · Europe PMC (PubMed Central) · Cited by 42
Modulation of NAD+ biosynthesis activates SIRT1 and resists cisplatin-induced ototoxicity
Zhan, T., Xiong, H., Pang, J., Zhang, W., Ye, Y., Liang, Z., Huang, X., He, F., Jian, B., He, W., et al. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.05.013 · Cited by 25
Nicotinamide Adenine Dinucleotide Deficiency and Its Impact on Mammalian Development
Dunwoodie, S. L., Bozon, K., Szot, J. O., & Cuny, H. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0349 · Cited by 24
“Consequently, NAD deficiency has been linked to several diseases and conditions, such as type 2 diabetes, cardiovascular disease, obesity, and inflammation, among other conditions (Aasheim et al., 2008; Allegri et al., 2003; Oxenkrug, 2013; Pillai et al., 2005; Yamamoto et al., 2014).”
Dhuguru, J., Dellinger, R. W., & Migaud, M. E. (2023) · Nutrients · doi:10.3390/nu15133064 · Cited by 26
Yu, X., Xue, M., Liu, Y., Zhou, Z., Jiang, Y., Sun, T., & Liang, H. W. (2020) · Food Science & Nutrition · doi:10.1002/fsn3.2007 · Cited by 25
Zhang, X., Zhang, Y., Sun, A., & Ge, J. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.04.001 · Cited by 26
Wang, X., Hu, X., Zhang, L., Xu, X., & Sakurai, T. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.04.022 · Cited by 24
Feng, D., Xu, D., Murakoshi, N., Tajiri, K., Qin, R., Yonebayashi, S., Okabe, Y., Li, S., Yuan, Z., Aonuma, K., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134655 · Cited by 23
The Role of Nicotinamide Mononucleotide Supplementation in Psoriasis Treatment
Zhang, Z., Cheng, B., Du, W., Zeng, M., He, K., Yin, T., Shang, S., Su, T., Han, D., Gan, X., et al. (2024) · Antioxidants · doi:10.3390/antiox13020186 · Cited by 24
Stojanović, D. R., Mitić, V., Stojanović, M., Petrović, D., Ignjatović, A., Milojković, M., Dunjić, O., Milenković, J., Bojanić, V., & Ilic, M. D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.691513 · Cited by 19
“Moreover, SIRT-1 is documented to exert protection against cardiac ischemic damage (34), and it may be presumed that is, at least partially, achieved by renalase action.”
BackgroundTechnology and functional insights into the nicotinamide mononucleotide for human health
Liu, Y., Gong, J., Marshall, G., Su, C., Shi, J., & Xu, Z. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12612-2 · Cited by 19
Gerő, D., & Szabó, C. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13252 · Cited by 19
“Both approaches have been effective in ischaemia-reperfusion injury of the heart (Sukhodub et al., 2010; Yamamoto et al., 2014).”
BackgroundTur, J., Chapalamadugu, K. C., Katnik, C. P., Cuevas, J., Bhatnagar, A., & Tipparaju, S. M. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00281.2016 · Cited by 18
The significance of caloric restriction mimetics as anti-aging drugs
Nassar, K., El-mekawey, D., Elmasry, A. E., Refaey, M. S., El-Sayed Ghoneim, M., & Elshaier, Y. A. M. M. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149354 · Cited by 16
Fadel, F., Al-Kandari, N., Khashab, F., Al-Saleh, F., & Al‐Maghrebi, M. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa074 · Cited by 16
Synthesis of NMN by cascade catalysis of intracellular multiple enzymes
Hua, W., Jiang, N., Wu, Y., Zhou, C.-L., Chen, K., & Wang, X. (2023) · RSC Advances · doi:10.1039/d3ra03857b · Cited by 16
Han, R., Huang, H., Zhu, J., Jin, X., Wang, Y., Xu, Y., & Xia, Z. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02357-w · Cited by 19
Xiao, Y., Phelp, P. G., Wang, Q., Bakker, D., Nederlof, R., Hollmann, M. W., & Zuurbier, C. J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.712478 · Cited by 16
Li, T., Yu, S., Zhou, C., Wang, K., & Wan, Y. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1616744 · Cited by 15
“Nampt, a ratelimiting enzyme that synthesise nicotinamide adenine dinucleotide (NADþ), can protect the heart from I/R injury [17].”
BackgroundRetractedMacrophage Metabolic Signaling during Ischemic Injury and Cardiac Repair
Thorp, E. B. (2021) · Immunometabolism · doi:10.20900/immunometab20210018 · Cited by 16
“In the heart, nicotinamide monoucleotide, an intermediate of NAD+ biosynthesis, was found to increase cardiac NAD+ and protect from coupled ischemia and reperfusion [103].”
BackgroundSun, L., & Zhang, W. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174142 · Cited by 15
Hu, Y.-R., Xing, S., Chen, C., Shen, D., & Chen, J.-L. (2019) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2019.09.002 · Cited by 15
Bai, L., Yau, L., Tong, T., Chan, W.-H., Zhang, W., & Jiang, Z. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.986 · Cited by 14
Wang, H., Liang, X., Luo, G., Ding, M., & Liang, Q. (2016) · Molecular BioSystems · doi:10.1039/c6mb00108d · Cited by 14
Hove, J. L. K. V., Friederich, M. W., Hock, D. H., Stroud, D. A., Caruana, N. J., Christians, U., Schniedewind, B., Michel, C. R., Reisdorph, R. M., Gonzalez, E. D. J. L., et al. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101905 · Cited by 13
Importance of NAD+ Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders
Helman, T. J., & Braidy, N. (2022) · Drugs & Aging · doi:10.1007/s40266-022-00989-0 · Cited by 15
“In xeroderma pigmentosum group A (XPA), a mitochondrial dysfunction disorder associated with severe neurodegeneration, the mitochondrial abnormalities appear to be associated with impaired activation of the NADSIRT1-PGC-1α axis in response to oxidative DNA damage and hyperactivation of PARP1 [17].”
BackgroundInfluentialEhrsam, J. P., Chen, J., Biefer, H. R. C., Opitz, I., Arni, S., & İnci, İ. (2022) · Antioxidants · doi:10.3390/antiox11050843 · Cited by 13
“Previous observations suggested that addition of NAD+ re-establishes the NAD+/NADH ratio and thus reduces ROS and consecutive organ damage [17,24].”
BackgroundCencioni, C., Atlante, S., Savoia, M., Martelli, F., Farsetti, A., Capogrossi, M. C., Zeiher, A. M., Gaetano, C., & Spallotta, F. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.005 · Cited by 12
NAD+ metabolism and retinal degeneration (Review)
Pîrvu, A. S., Andrei, A. M., Stănciulescu, E. C., Baniţă, I. M., Pisoschi, C. G., Jurja, S., & Ciuluvica, R. C. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10102 · Cited by 13
“such as the pancreas, liver and white adipose tissue of diabetic mice (21), heart (31,32), skeletal muscle (33), kidney (34,35), eyes (36) and blood vessels (37,38).”
BackgroundLiu, X., Li, D., Liu, Z., Song, Y., Zhang, B., Zang, Y., Zhang, W., Niu, Y., & Shen, C. (2022) · Burns · doi:10.1016/j.burns.2022.01.013 · Cited by 12
Du, Z.-C., Li, G., Luo, Y., Bai, X., & Sun, B. (2023) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000131 · Cited by 11
“Evidence suggested that NMN supplementation could boost cellular NAD concentrations with lower adverse effects and toxicity, which alleviate oxidative stress, insulin resistance, and ischemic-reperfusion injury [66] by activating SIRT protein family.”
BackgroundTian, H., Zhao, X., Zhang, Y., & Xia, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28738 · Cited by 13
“Nicotinamide adenine dinucleotide (NAD) protects the heart from ischemia-reperfusion injury [92].”
BackgroundDNA Methylation Ageing Atlas Across 17 Human TissuesPreprint
Jacques, M., Seale, K., Voisin, S. A. C., Lysenko, A., Grolaux, R., Jones, B., Lamon, S., Levinger, I., Bauer, C., Sharples, A. P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.21.665830 · Cited by 13
Function of NAD metabolism in white adipose tissue: lessons from mouse models
Kwon, S. Y., & Park, Y. J. (2024) · Adipocyte · doi:10.1080/21623945.2024.2313297 · Cited by 10
“In the heart, boosting NAD+ prevents NAD+ depletion during ischaemia and protects against reperfusion injury through SIRT1-mediated forkhead box protein O1 (FOXO1) deace-tylation [40].”
Background
Metadata
- Authors
- Yamamoto, T., Byun, J., Zhai, P., Ikeda, Y., Oka, S., & Sadoshima, J.
- Affiliations
- Rutgers New Jersey Medical School (US)
- Corresponding author
- Sadoshima, Junichi
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-06-06
- Volume
- 9
- Issue
- 6
- Pages
- e98972
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4048236
- OpenAlex
- W2163282809
- Cited by
- 305
- References
- 29
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 29 · 2023: 32 · 2022: 30 · 2021: 34 · 2020: 34 · 2019: 18 · 2018: 29 · 2017: 20 · 2016: 24 · 2015: 16 · 2014: 1
- FWCI
- 15.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fondation Leducq (HL69020, HL67724, AG27211, HL91469, HL102738)
- U.S. Public Health Service (HL91469, AG27211, HL67724, HL69020, HL102738, HL59139)
- National Institute on Aging (P01AG027211, R01AG023039, AG27211)
- National Heart, Lung, and Blood Institute (HL59139, HL91469, R01HL067724, HL69020, HL102738, R01HL102738, R01HL112330, HL-67724, P01HL059139, P01HL069020, R01HL091469)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- nicotinamide mononucleotide, NAD+ salvage pathway, visfatin, SIRT1, ischemia-reperfusion injury, myocardial ischemia, ischemic preconditioning, caloric restriction, cardioprotection, NAD+ depletion
- MeSH terms
- Animals, Cardiotonic Agents, Heart, Male, Myocardial Infarction, NAD, Nicotinamide Mononucleotide, Reperfusion Injury, Up-Regulation, Myocardial Ischemia, Ischemic Preconditioning, Caloric Restriction, Mice, Nicotinamide Phosphoribosyltransferase, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.